Linhua Lan

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Huimin Huang · 7 shared papers, 2021–2026 · strength 1.30
   • Paper BCAT1 inhibits glutamine-dependent Akt/mTOR signaling and nucleotide synthesis by initiating BTRC-mediated degradation … DOI 10.1186/s40170-026-00436-3↗
   • Paper Construction of a metabolism-related gene prognostic model to predict survival of pancreatic cancer patients. DOI 10.1016/j.heliyon.2022.e12378↗
   • Paper Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocar… DOI 10.1016/j.canlet.2024.216806↗
2. Guihua Jin · 6 shared papers, 2021–2026 · strength 1.13
   • Paper BCAT1 inhibits glutamine-dependent Akt/mTOR signaling and nucleotide synthesis by initiating BTRC-mediated degradation … DOI 10.1186/s40170-026-00436-3↗
   • Paper RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocar… DOI 10.18632/aging.203589↗
   • Paper Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocar… DOI 10.1016/j.canlet.2024.216806↗
3. Fugen Shangguan · 3 shared papers, 2021–2022 · strength 0.48
   • Paper RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocar… DOI 10.18632/aging.203589↗
   • Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
   • Paper 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Ca… DOI 10.1016/j.phymed.2022.154164↗
4. Shijia Wu · 3 shared papers, 2022 · strength 0.43
   • Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
   • Paper A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in p… DOI 10.1186/s12935-022-02562-6↗
   • Paper 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Ca… DOI 10.1016/j.phymed.2022.154164↗
5. Hongping Xia · 3 shared papers, 2021–2022 · strength 0.39
   • Paper 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Ca… DOI 10.1016/j.phymed.2022.154164↗
   • Paper Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progressio… DOI 10.1016/j.ygeno.2020.10.039↗
   • Paper S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways. DOI 10.1007/s10565-020-09574-w↗
6. Xiaoqun Zheng · 2 shared papers, 2022–2024 · strength 0.36
   • Paper Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocar… DOI 10.1016/j.canlet.2024.216806↗
   • Paper Single-Cell Transcriptome Reveals the Metabolic and Clinical Features of a Highly Malignant Cell Subpopulation in Pancr… DOI 10.3389/fcell.2022.798165↗
7. Percy David Papa Akuetteh · 2 shared papers, 2022 · strength 0.29
   • Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
   • Paper A synthesized olean-28,13β-lactam targets YTHDF1-GLS1 axis to induce ROS-dependent metabolic crisis and cell death in p… DOI 10.1186/s12935-022-02562-6↗
8. Xiao Mo · 2 shared papers, 2021 · strength 0.25
   • Paper Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progressio… DOI 10.1016/j.ygeno.2020.10.039↗
   • Paper S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways. DOI 10.1007/s10565-020-09574-w↗
9. Liyi Li · 1 shared paper, 2023 · strength 0.20
   • Paper Construction of a metabolism-related gene prognostic model to predict survival of pancreatic cancer patients. DOI 10.1016/j.heliyon.2022.e12378↗
10. Qingqing Ruan · 1 shared paper, 2021 · strength 0.19
    • Paper RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocar… DOI 10.18632/aging.203589↗
11. Hongping Xia · 1 shared paper, 2024 · strength 0.19
    • Paper Lactate enhances NMNAT1 lactylation to sustain nuclear NAD+ salvage pathway and promote survival of pancreatic adenocar… DOI 10.1016/j.canlet.2024.216806↗
12. Yangyang Fang · 1 shared paper, 2022 · strength 0.17
    • Paper Single-Cell Transcriptome Reveals the Metabolic and Clinical Features of a Highly Malignant Cell Subpopulation in Pancr… DOI 10.3389/fcell.2022.798165↗
13. Hongbao Yang · 1 shared paper, 2022 · strength 0.15
    • Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
14. Qiyu Zhang · 1 shared paper, 2022 · strength 0.15
    • Paper Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenoc… DOI 10.1002/jbt.23192↗
15. Nengfang Ma · 1 shared paper, 2022 · strength 0.14
    • Paper 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Ca… DOI 10.1016/j.phymed.2022.154164↗
16. Hailong Yang · 1 shared paper, 2022 · strength 0.14
    • Paper 6-methoxydihydroavicine, the alkaloid extracted from Macleaya cordata (Willd.) R. Br. (Papaveraceae), triggers RIPK1/Ca… DOI 10.1016/j.phymed.2022.154164↗
17. Hongjin Chen · 1 shared paper, 2021 · strength 0.13
    • Paper Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progressio… DOI 10.1016/j.ygeno.2020.10.039↗
18. Xiaoming Wang · 1 shared paper, 2021 · strength 0.13
    • Paper Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progressio… DOI 10.1016/j.ygeno.2020.10.039↗
19. Alaa Abdelatty · 1 shared paper, 2021 · strength 0.12
    • Paper S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways. DOI 10.1007/s10565-020-09574-w↗
20. Dan Fang · 1 shared paper, 2021 · strength 0.12
    • Paper S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways. DOI 10.1007/s10565-020-09574-w↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.